Accure Acne Launches Personal Placement Providing On M-Vest Platform To Lift As Much As $20 Million

Friday, April 23, 2021 Tags: Boulder, Accure Acne, R. Rox Anderson

BOULDER — Accure Acne Inc. introduced that it has launched a personal placement providing on the M-Vest platform to lift as much as $20 million.

Accure has developed an energy-based gadget known as the “Accure Laser System(R)” that targets sebaceous glands within the pores and skin. Building on the analysis of R. Rox Anderson, Accure co-founder and Chief Scientific & Medical Officer, Accure developed the Accure laser system which they consider makes use of a brand new, patented therapy technique that has been proven on human tissue to wreck the sebaceous glands by selective photothermolysis, whereas the encompassing dermis is spared from injury.

In March 2020, Accure’s unique manufacturing accomplice for the Accure Laser System, Quanta System SpA, acquired CE Mark approval. Accure stated it believes that is the one 1726nm laser with CE Mark clearance for the therapy of average inflammatory zits.

Accure’s first FDA pivotal trial was paused in March 2020 because of the COVID-19 pandemic. In December 2020, Accure acquired IRB approval to restart their FDA pivotal investigation. As a end result, the pivotal FDA examine started recruiting topics in December 2020 and resumed therapy in January 2021.

Accure stated this funding carries a excessive diploma of threat and shouldn’t be made by somebody who can not afford to lose his or her whole funding. This funding is very speculative and illiquid and potential buyers ought to contact the Accure Acne, Inc. Subscription Agreement and Limited Liability Business Agreement earlier than investing.

This funding is for accredited buyers solely. No provide to promote securities, nor solicitation of a suggestion to purchase securities, is being made in any jurisdiction the place such provide, sale or solicitation isn’t permitted by relevant legislation, Accure stated.


Leave a Comment